Клиническая фармакология [Архив] - медицинсий форум

PDA

Просмотр полной версии : Клиническая фармакология


Наталья П.
07.05.2005, 09:20
Клиническая фармакология

Tanya_M
08.12.2005, 14:06
[Ссылки могут видеть только зарегистрированные и активированные пользователи]

Pharmacological Reviews Online
New PharmGKB Submission Updates Available

yananshs
17.01.2006, 18:48
Drug Reference Resources

[Ссылки могут видеть только зарегистрированные и активированные пользователи]


Наталья П.
01.09.2006, 19:48
Составитель: Ирина Ибрагимова
Координатор по медицинским информационным ресурсам
Американский международный союз здравоохранения

Информация о лекарственных препаратах в интернете

Drugs.сom
(на англ.яз)
Информация о рецептурных лекарственных препаратах, адресованная потребителям и специалистам в США. Возможность быстрого поиска среди более чем 24 тыс. утвержденных препаратов, в том числе с указанием побочных эффектов и лекарственных взаимодействий. Информационную базу данных ресурса Drugs.com обеспечивают три независимых ведущих источника медицинской информации: Physicians’ Desk Reference, Cerner Multum и Thomson Micromedex. Drugs.com представляет информацию об отдельных препаратах (или группах препаратов), подготовленную этими источниками, в полном объеме и без изменения содержания. Разделы «Последние новости» ("Latest News") и «Управление по контролю качества предупреждает» ("FDA Drug Alerts") подготовлены штатными сотрудниками Drugs.com или специалистами медицинских журналов. Актуальная медицинская информация, представленная в разделе «Категории» ("Categories"), поступает из компании Micromedex и обобщается штатными фармацевтами. Кроме того, на сайте содержится раздел «Идентификация таблеток» (Pill Identification Wizard) и опции для поиска внешнего вида препаратов.
URL:
[Ссылки могут видеть только зарегистрированные и активированные пользователи]


Информация о лекарственных препаратах, предоставляемая Управлением по контролю качества пищевых продуктов и лекарственных средств (FDA Drug Information)
(на англ.яз)
Управление по контролю качества пищевых продуктов и лекарственных средств – Центр по оценке и исследованию свойств лекарственных препаратов. Информация о лекарственных средствах представлена следующими ресурсами: «Разрешенные к применению новые рецептурные лекарственные препараты»; «Информация о рецептурных лекарственных препаратах»; «Основные информационные страницы о лекарственных препаратах»; «Лекарственные препараты: информация для потребителей»; «Безрецептурные лекарственные препараты»; «Безопасность и побочные эффекты лекарственных препаратов»; «Предупреждения об опасности для здоровья»; «Доклады и публикации»; «Специальные проекты и программы»; «Полезные ресурсы».
URL:
[Ссылки могут видеть только зарегистрированные и активированные пользователи]


MedlinePlus: Drugs, Supplements, and Herbal Information (Информация о лекарственных средствах, добавках и фитопрепаратах)
(на англ.яз)
Информация для потребителей. Сведения о рецептурных и безрецептурных лекарственных средствах поступает из баз данных MedMaster (продукт Американского общества фармацевтов системы здравоохранения) и USP DI Advice for the Patient (продукт организации «Фармакопея США»). Сведения о фитопрепаратах и добавках поступают из базы данных Natural Standard.
URL:
[Ссылки могут видеть только зарегистрированные и активированные пользователи]


Rxlist
(на англ.яз)
Информация для потребителей и специалистов здравоохранения. Позволяет проводить поиск по ключевым словам, побочным эффектам, лекарственным взаимодействиям, содержит информацию о лекарственных препаратах, названия препаратов, идентификацию таблеток, отштампованные коды, коды Национального кода лекарственных средств, медицинскую терминологию и информацию для пациентов. Раздел «300 ведущих лекарственных препаратов 2005 г.) (Top 300 Drugs of 2005) содержит информацию о наиболее часто выписываемых рецептурных лекарственных средств со ссылками на разделы «Побочные эффекты», «Лекарственные взаимодействия», «Дозировка», «Применение», и «Предупреждение».
URL:
[Ссылки могут видеть только зарегистрированные и активированные пользователи]


Веб-сайт Американской ассоциации пенсионеров «Сравнение рецептурных препаратов (AARP Prescription Drug Comparison Web-site)
(на англ.яз)
Данный веб-сайт позволяет жителям США сравнить «безопасность, эффективность и стоимость» рецептурных препаратов. На нем представлены данные о лекарственных препаратах для 16 медицинских состояний и сведения об альтернативных генериках и их ценах. Информация основана на независимом анализе и оценке имеющихся медицинских данных, полученных от Орегонского центра научно обоснованной практики (в рамках проекта «Анализ эффективности лекарственных препаратов»).
URL:
[Ссылки могут видеть только зарегистрированные и активированные пользователи]

Наталья П.
01.03.2007, 17:29
[Ссылки могут видеть только зарегистрированные и активированные пользователи]
US Drug and Food Administration

The FDA Safety Information and Adverse Event Reporting Program

Welcome to MedWatch, your Internet gateway for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration.

также можно подписаться на рассылку и самому сообщить о побочных эффектах

Наталья П.
11.11.2007, 13:49
Strategies To Improve Communication Between Pharmacy Staff and
Patients
Training Program for Pharmacy Staff
Curriculum Guide

This training program is designed to introduce pharmacists to the problem of low health literacy in patient populations and to identify the implications of this problem for the delivery of health care services. The program also explains techniques that pharmacy staff members can use to improve communication with patients who may have limited health literacy skills. This training curriculum was produced under contract to the Agency for Healthcare Research and Quality (AHRQ)

[Ссылки могут видеть только зарегистрированные и активированные пользователи]

to download print version (PDF File, 240 KB)

[Ссылки могут видеть только зарегистрированные и активированные пользователи]


Наталья П.
27.11.2007, 22:12
PDRhealth
[Ссылки могут видеть только зарегистрированные и активированные пользователи]

"PDRhealthTM is the consumer Web portal of the Physicians’ Desk Reference
(PDR®), which has provided... drug and clinical information to physicians for over 60 years.
The PDRhealth site offers consumer-friendly explanations of disease states and conditions as well as the safe and effective use of prescription and non-prescription drugs as well as herbal medicines. "

Editorial Policy

"Our goal is to bring you current, accurate, and helpful information about drugs, herbal medicines and supplements, as well as common diseases and conditions. The drug information on PDRhealth is written in lay terms and is based on the FDA-approved drug information found in the PDR or from manufacturers.
It gives consumers plain-English explanations for the safe and effective use of prescription and nonprescription drugs—explanations that are consistent with the information professionals reference in the PDR.

The disease and condition information covers the most common ailments one is likely to encounter. The articles, which are written and reviewed by physicians and other clinical professionals, aim to give you a comprehensive overview of the conditions—from symptoms to diagnosis and even self-care.

While great care has been taken in organizing and presenting the material on PDRhealth, please note that information on a web site should never be substituted for the advice of your doctor or other health professional.

[Ссылки могут видеть только зарегистрированные и активированные пользователи]


This is an example of an article on Echinacea:

[Ссылки могут видеть только зарегистрированные и активированные пользователи]

Echinacea
What is it?

Echinacea is an herbal medicine used to treat a cold or flu. It may also be used to help your body fight a urine infection (urinary tract infection). Some cancers have been treated with Echinacea and the effect of chemotherapy may be improved with Echinacea.

Other names for Echinacea include: Echinacea purpura , American coneflower, Purple coneflower, Kansas snakeroot, Indian Head, Hedgehog, Black Sampson, Black Susan, and Comb flower.

Ask your doctor, nurse, or pharmacist if you need more information about this medicine or if any information in this leaflet concerns you.

Before Using:
Tell your doctor if you

are taking medicine or are allergic to any medicine (prescription or over-the-counter (OTC) or dietary supplement)
are pregnant or plan to become pregnant while using this medicine
are breastfeeding
have multiple sclerosis (MS), human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), an autoimmune disease (such as lupus), or tuberculosis (TB)
have any other health problems, such as high blood pressure or heart or blood vessel disease

Dosage:
Talk with your caregiver about how much Echinacea you should take. The amount depends on the strength of the medicine and the reason you are taking Echinacea. If you are using this medicine without instructions from your caregiver, follow the directions on the medicine bottle. Do not take more medicine or take it more often than the directions tell you to.

To store this medicine:
Keep all medicine locked up and away from children. Store medicine away from heat and direct light. Do not store your medicine in the bathroom, near the kitchen sink, or in other damp places. Heat or moisture may cause the medicine to break down and not work the way it should work. Throw away medicine that is out of date or that you do not need. Never share your medicine with others.

Drug and Food Interactions:
Do not take Echinacea without talking to your doctor first if you are taking:


Medicine that decreases the immune system functioning (examples: azathioprine (Imuran(R)), basiliximab (Simulect(R)), prednisone (Deltasone(R), Meticorten(R)), methylprednisolone (Solu-Medrol(R)), cortisone (Cortone(R)), prednisolone (Pediapred(R)), cyclosporine (Neoral(R), Sandimmune(R)), daclizumab (Zenepax(R)), muromonab (Orthoclone OKT3(R)), mycophenolate (Cellcept(R)), sirolimus (Rapamune(R)), tacrolimus (Prograf(R)))

Warnings:

Before taking Echinacea, tell your doctor if you are pregnant or breastfeeding
Echinacea should not be used orally (by mouth) in long term diseases, such as multiple sclerosis, tuberculosis, collagenosis, and autoimmune disorders (like lupus or rheumatoid arthritis)
Echinacea should not be used orally (by mouth) in long term diseases, such as HIV or AIDS

Side Effects:
Stop taking your medicine right away and talk to your doctor if you have any of the following side effects. Your medicine may be causing these symptoms which may mean you are allergic to it.

Breathing problems or tightness in your throat or chest
Chest pain
Skin hives, rash, or itchy or swollen skin

Other Side Effects:
You may have the following side effects, but this medicine may also cause other side effects. Tell your doctor if you have side effects that you think are caused by this medicine.

Dizziness, headache, fever, nausea (upset stomach), or skin irritation

References:
1. Schulz V & Haensel R: Rationale Phytotheapie. Ratgeber fuer die aertzlich Praxis. 3 Aufl. Springer Verlag, Berlin, 1996:306-310.
2. Blumenthal M, Busse WR, Goldberg A et al: The Complete Commission E Monographs; Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX; 1998.
3. Brinker F: Herb Contraindications and Drug Interactions. Eclectic Medical Publications, Sandy, OR; 1998.
4. Anon: ABDA-Datenbank WuV, Eschborn and Micromedex Inc, Englewood, CO; 1997.
5. Bisset NG: Herbal Drugs and Phytopharmaceuticals. CRC Press, Boca Raton, FL; 1994.
6. Berg AH, Northoff D, Konig C et al: Influence of Echinacin(R) (EC31) treatment on the exercise-induced immune response in athletes. J Clin Res 1998; 1:367-380.

Наталья П.
14.02.2008, 20:01
The National Library of Medicine releaseв of the
NLM Drug Information Portal.

The site is at [Ссылки могут видеть только зарегистрированные и активированные пользователи]

The NLM Drug Information Portal gives the public, healthcare professionals,
and researchers a gateway to current, accurate and understandable drug information from the National Library of Medicine and other key government agencies.

At the top of the page are links to individual resources with potential drug information, including summaries tailored to various audiences. Resources include the NLM search systems useful in searching for a drug, NLM research resources, resources organized by audience and class, and other NIH and government resources such as FDA and CDC.

The search box in the middle of the page lets you search many of these resources simultaneously. More than 12,000 drugs can be searched using this facility. The portal covers drugs from the time they are entered into clinical trials (Clinicaltrials.gov) through their entry in the market place (Drugs@FDA). The PubMed/Medline link provides medical literature describing research, and TOXLINE provides toxicology literature. Resources such as MedlinePlus provide easy to read summaries of the uses and efficacy of a drug.

You may search by a drug’s trade name or generic name. For example, the trade name “Advil” and the generic name “ibuprofen” will retrieve the same drug record. A spell checker gives suggestions if the name is not found. You can find embedded portions of names by using an asterisk at the beginning and/or end of a search term. Once a drug is found, a summary of the drug’s type and usage is given, as well as links leading to further information at one of the portal’s resources. Outside links open in a new window. Within a given drug record, you may click on the drug category and retrieve drugs with the same or similar uses.

JavaScript must be enabled in your browser for the NLM Drug Information
Portal to work properly.

Наталья П.
04.11.2008, 12:08
New Version of Drug Information Portal
[Ссылки могут видеть только зарегистрированные и активированные пользователи]

A new version of the National Library of Medicine's Drug Information Portal is now available. The portal now covers over 15,000 drugs. Current information regarding consumer health, clinical trials, AIDS-related drug information, MeSH pharmacological actions, PubMed biomedical literature, and physical properties and structure is easily retrieved by searching a drug name.

The NLM Drug Information Portal gives users a gateway to selected drug information from the U.S. National Library of Medicine and other key U.S. Government agencies. At the top of the page are links to individual resources with potential drug information, including summaries tailored to various audiences. Resources include the NLM search systems useful in searching for a drug, NLM research resources, resources organized by audience and class, and other NIH and government resources such as FDA and CDC.

The search box in the middle of the page lets you search many of these resources simultaneously. More than 15,000 drugs can be searched using this facility. The portal covers drugs from the time they are entered into clinical trials (Clinicaltrials.gov) through their entry in the U.S. market place (Drugs@FDA). Many drugs in other countries are covered, but not as thoroughly as U.S. drugs. The PubMed link provides medical literature describing research, and TOXLINE provides toxicology literature. Resources such as MedlinePlus provide easy to read summaries of the uses and efficacy of a drug.


Наталья П.
24.10.2009, 19:16
спасибо LupusDoc

Meyler's Side Effects of Drugs - самое полное руководство по нежелательным эффектам лексредств.
Последнее издание 15-ое, вышло в 2006 году, имеет около 5000 страниц.
купить :)
[Ссылки могут видеть только зарегистрированные и активированные пользователи]

Наталья П.
29.08.2010, 13:30
A Practical Approach to Pharmaceutical Policy

Andreas Seiter

June 2010 by World Bank ISBN: 0-8213-8386-8 ISBN-13: 978-0-8213-8386-5 SKU: 18386



Book [240p] available online at: [Ссылки могут видеть только зарегистрированные и активированные пользователи]

“………..Pharmaceuticals are an essential component of health care. But for many people in low- and middle-income countries, access to the medicines they need to prevent or treat severe illnesses is limited. Typical problems are lack of availability, costs that exceed the individual’s purchasing power or lack of competent “agents” – health workers that are well trained to give the correct advice on which medicines to take.

Pharmaceutical policy is the part of health policy that aims at addressing these problems and increasing access to safe, effective and affordable medicines for all patients. There are many obstacles against achieving these goals. Such obstacles can arise from financial interests on the side of suppliers and health care providers, who may benefit from charging higher prices and issuing more prescriptions than might be justified from a clinical and economic viewpoint. Or from rogue suppliers trying to introduce low quality or counterfeit drugs into markets with less effective regulation. Also, corruption and ineffective bureaucracies sometimes interfere with well intended programs to offer access to essential medicines for the poor.

This book offers policy makers a hands-on approach, tested in the World Bank’s field work in many countries, for assessing the pharmaceutical sector, recognizing typical “patterns of dysfunction” and developing strategies to quickly deal with the most urgent problems while at the same time building a platform for sustainable long term policy. It offers examples from a variety of low- and middle income countries and provides practical assessment tools for policy makers. The book ends with the author’s outlook on future developments in this complex policy field…………”

TABLE OF CONTENTS

Chapter 1. Pharmaceutical Policy Goals
Pharmaceutical Policy Framework • Parameters for Monitoring the Effect and Progress of Pharmaceutical Reforms

Chapter 2. Introducing the Stakeholders
Multinational Research-Based Companies • Multinational Generics Companies • National Generics Companies • Brokers • Procurement Agents • Importers and Agents • Wholesalers • Central Medical Stores • Retail Pharmacists and Drug Sellers • Prescribers • Consumers • Public Policy Makers: Legislative and Executive • Regulatory and Executive Agencies • Expert Commissions and Advisers • Civil Society Organizations • International Agencies and Donors • Public Purchasers • Payers • Pharmaceutical Benefit Managers • Consultants

Chapter 3. Patterns of Dysfunction
Inadequate Regulation of Core Pharmaceutical Sector Functions • Lack or Misuse of Funds • Ineffective or Inefficient Procurement • Dysfunctional Supply Chains • Corruption, Abuse of Public Funds, and Unethical Business Practices • Inadequate Incentives for Providers and Policy Makers • Medicine Prices Perceived as Too High • Conflicts between Innovation and Cost Containment • Conflicts between Industrial Policy and Public Health Objectives • Irrational or Inappropriate Use of Drugs • A Tool to Assess the Sector and Diagnose Dysfunctions

Chapter 4. Key Elements of a Successful Pharmaceutical Policy
Ensuring Access to Safe and Effective Drugs through Well-Designed Supply Chains • Using Purchasing Power to Get Value for Money • Managing the Decision Process on Formulary Inclusion • Creating Adequate Information Systems • Ensuring Rational and Cost-Effective Use of Medicines • Securing Adequate Financing and Payment Mechanism for Pharmaceuticals • Reconciling Health Policy and Industrial Policy in the Pharmaceutical Sector • Ensuring Good Governance of the Sector

Chapter 5. Policy Packages to Achieve Strategic Long-Term Goals
Essential Medicines Policy • Generic Drugs Policy • Innovation-Friendly Drugs Policy • Combining Several Policy Models within One Country

Chapter 6. Factors Influencing Policy Implementation
Stakeholder Assessment and Involvement • Strategies to Neutralize Political Opposition

Chapter 7. Pharmaceutical Policy Illustrated in Country Examples
Ghana: National Health Insurance as a A?Game ChangerA? • Lithuania: Dealing with the Effects of the Financial Crisis • China: Improving Social Protection for the Rural Poor • Russian Federation: Affordability and Access to Essential Drugs • Liberia: Building Up after Conflict

Chapter 8. Pharmaceutical Policy Outlook
Regulatory Framework • Drug Prices • Financing and Management of Drug Benefits • Effect on Markets and Industry • General Trend: Convergence toward Models That Work

Vlad34
15.10.2010, 23:43
Новый журнал издательства Sage.
Therapeutic Advances in Drug Safety ([Ссылки могут видеть только зарегистрированные и активированные пользователи])